金沙集团1862cc(股份)有限公司-baidu百科

Products

We are dedicated to researching and developing novel therapeutics for the treatment of cancer, autoimmune, cardiovascular diseases, and other serious unmet medical needs

Process and Manufacture

We have established a comprehensive quality management system in compliance with requirements applicable to and enforced by global competent authorities

Explore Further

Company News

Bio-Thera Solutions Expands Partnership with Dr. Reddy’s through an Exclusive Commercialization and License Agreement for BAT2306, a Proposed Biosimilar Candidate to Cosentyx® (Secukinumab), in Southe

Guangzhou, China; November 10, 2025: Bio-TheraSolutions (688177:SH; “Bio-Thera”), a commercial-stage biopharmaceuticalcompany developing a pipeline of innovative therapies and biosimilars, today annou...

Bio-Thera Solutions Announces the Launch of STARJEMZA® (ustekinumab-hmny) in the United States

GUANGZHOU,China - Bio-Thera Solutions (688177.SH), a commercial-stage biopharmaceutical companydeveloping innovative therapies and biosimilars, announced that its partner, HikmaPharmaceuticals USA Inc...

Bio-Thera Solutions Announces Expansion of Partnership with Intas Pharmaceuticals for BAT2506, a Proposed Biosimilar Referencing Simponi® (golimumab), through Exclusive Commercialization and License A

GUANGZHOU, China --- Bio-Thera Solutions (688177:SH), a commercial-stage biopharmaceuticalcompany developing a pipeline of innovative therapies and biosimilars, todayannounced an expansion of its part...

XML 地图